MoneyWorks4Me

Dr. Lal PathLabs informs about investor presentation

31 Jul 2025 Evaluate
Dr. Lal PathLabs has attached a copy of Company's Q1 FY26 Earnings Presentation, which the Company proposes to share with Analysts/ Investors with respect to its Un-Audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2025, as approved by the Board of Directors in their meeting held on July 31, 2025. 

The above information is a part of company’s filings submitted to BSE.
Peers